GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (FRA:AS0) » Definitions » Float Percentage Of Total Shares Outstanding

DMS Imaging (FRA:AS0) Float Percentage Of Total Shares Outstanding : 0.00% (As of Jun. 08, 2024)


View and export this data going back to 2021. Start your Free Trial

What is DMS Imaging Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, DMS Imaging's float shares is 0.00 Mil. DMS Imaging's total shares outstanding is 1,489.61 Mil. DMS Imaging's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, DMS Imaging's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, DMS Imaging's Institutional Ownership is 0.01%.

DMS Imaging Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

DMS Imaging's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/1,489.61
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DMS Imaging (FRA:AS0) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » DMS Imaging SA (FRA:AS0) » Definitions » Float Percentage Of Total Shares Outstanding
Comparable Companies
XBRU:CYAD XBRU:BIOS XBRU:OXUR XBRU:ONWD OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN
Traded in Other Exchanges
ALIMG:Belgium
Address
7 Rue des Chasseurs Ardennais, Liege, BEL, 4031
Website
https://www.dms-imaging.com
DMS Imaging SA is a clinical-stage biopharmaceutical company. The company is engaged in the development and future commercialization of a range of breakthrough immunotherapy products for the treatment of allergies, based on its ASIT+ technology platform. Its lead product is gp-ASIT+, a phase III trial for the treatment of grass pollen rhinitis. Its pipeline products consist of hdm-ASIT+ for the treatment of house dust mite asthma; and pnt-ASIT+ for the treatment of peanut allergy.

DMS Imaging (FRA:AS0) Headlines

No Headlines